MegaPro Biomedical Co., Ltd (TPEX:6827)
Taiwan
· Delayed Price · Currency is TWD 12.70
-0.20 (-1.55%)
Apr 29, 2026, 1:56 PM CST
MegaPro Biomedical Market Cap
MegaPro Biomedical has a market cap or net worth of 821.96 million as of April 29, 2026. Its market cap has increased by 5.39% in one year.
Market Cap
821.96M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
12.70
Market Cap Chart
Since October 19, 2021, MegaPro Biomedical's market cap has decreased from 2.11B to 821.96M, a decrease of -61.11%. That is a compound annual growth rate of -18.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 29, 2026 | 834.90M | 3.61% |
| Dec 31, 2025 | 805.78M | -14.43% |
| Dec 31, 2024 | 941.69M | -32.75% |
| Dec 29, 2023 | 1.40B | 24.04% |
| Dec 30, 2022 | 1.13B | -38.43% |
| Dec 30, 2021 | 1.83B | -13.24% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Neith | 793.51M |
| NatureWise Biotech & Medicals | 897.75M |
| BioLASCO Taiwan | 755.55M |
| SynCore Biotechnology Co.,Ltd | 698.02M |
| TCI GENE | 1.01B |
| Lukas Biomedical | 1.01B |
| TaiwanJ Pharmaceuticals | 657.80M |
| Vectorite Biomedical | 650.00M |